Class of 2026
For remarkable research contributions to uncovering fundamental metabolic pathways in cancer onset and progression, including characterizing the tumor-specific use of glycolysis and amino acid metabolism, Ras-driven macropinocytosis, and the oncogenic role of 2-hydroxyglutarate, which has informed innovative strategies for early cancer detection, targeted therapy, and precision oncology.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]